TITLE

DTC user fee plan canned

AUTHOR(S)
M. A.
PUB. DATE
February 2008
SOURCE
Medical Marketing & Media;Feb2008, Vol. 43 Issue 2, p28
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that the Food and Drug Administration (FDA) has advised that the direct-to-consumer (DTC) television (TV) advertising user program will not commence as required by the FDA Amendments Act of 2007 (FDAAA) in the U.S. The user fee program for advisory review of advertisements will allow companies to voluntarily submit TV advertisements for fast-track review before they aired. But, an appropriations bill signed by President George W. Bush does not provide funds for reviews.
ACCESSION #
29968108

 

Related Articles

  • Presenting Risk in Drug Advertising. Heisey, Colleen; Chernove, Arianna // Contract Pharma;Sep2010, Vol. 12 Issue 7, p18 

    The article focuses on the publication of a proposed rule by the U.S. Food and Drug Administration (FDA) that is aimed for the amendment of radio and television direct-to-consumer (DTC) advertising regulations for prescription drugs. The amendment seeks to include standards by which FDA will...

  • New legislation puts clinical trials in US "public arena.".  // Reactions Weekly;11/3/2007, Issue 1176, p1 

    The article concerns the Food and Drug Administration (FDA) Revitalization Act signed into law by U.S. President George W. Bush. The law enables the FDA to request the completion of safety studies after drug marketing when deemed necessary, the alteration of drug labels to reflect new...

  • DRUG ADS under the microscope.  // Marketing Management;Jul/Aug2008, Vol. 17 Issue 4, p7 

    The article reports that U.S. Congressional Democrats want legislation to increase drug marketing controls including giving the U.S. Food and Drug Administration the right to force changes in television drug advertisements before they are broadcast, according to a report in "The Wall Street...

  • Marketers Ante Up for Ad Reviews. J. W. // Pharmaceutical Executive;Jan2008, Vol. 28 Issue 1, p20 

    The article reports that the new fee-for-direct to consumer (DTC) advertisement (ad) review program of the U.S. Food and Drug Administration (FDA) has received several commitments from marketers by November 2007 sign-up rolling. According to the author, 31 marketing entities have filed requests...

  • FDA close to easing limits on Rx TV ads. Wilke, Michael // Advertising Age;6/30/1997, Vol. 68 Issue 26, p1 

    The article reports on a United States Food and Drug Administration (FDA) official's claim that the agency is considering allowing marketers to name both a prescription drug and the ailment it treats in consumer advertising. Such a change in the FDA guidelines for advertising could bring an...

  • Marketers Lobby FDA. J. W. // Pharmaceutical Executive;May2006, Vol. 26 Issue 5, p28 

    The article reports that the advertising and public relations industry groups have petition the U.S. Food and Drug Administration (FDA) to revise its rules governing direct-to-consumer (DTC) advertising. Despite the possibility that the FDA will not revise its rules, the request may focus...

  • TV Ad Fees Spark Criticism. Wechsler, Jill // Pharmaceutical Executive;Apr2007, Vol. 27 Issue 4, p24 

    The article reports that the drug makers' move to pay the U.S. Food and Drug Administration (FDA) for direct-to-consumer (DTC) advertising of drugs has been opposed by critics due to a fear that such reviews are uncertain to be paid for by industry. Such program was criticized because it was...

  • Adults Only. Parry, Tim // Promo;Oct2005, Vol. 18 Issue 11, p15 

    Reports on the release of pharmaceutical industry guidelines for types of advertisements targeting seniors that are pushed back to late-night television. Changes in the ways the pharmaceuticals market promote any new drugs that come down the line according to the Pharmaceutical Research and...

  • FDA to study DTC ads.  // Medical Device Daily;6/23/2009, Vol. 13 Issue 119, p6 

    The article reports on the plan of the U.S. Food and Drug Administration (FDA) to take up a study of the impact of how benefit information is presented in direct-to-consumer (DTC) advertisements on the perception of benefit. The study, announced in the "Federal Register," is intended to compare...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics